CJC-1295 Overview

CJC-1295 is a modified GHRH analog with 29 amino acids. The DAC (Drug Affinity Complex) version binds to albumin, extending its half-life to approximately 8 days. This allows for less frequent administration in research protocols while maintaining elevated GH levels.

Sermorelin Overview

Sermorelin is a 29-amino acid analog of GHRH(1-44) that was previously FDA-approved for diagnostic use. It has a short half-life of approximately 10-20 minutes, producing GH release patterns that closely mimic natural physiology. It has one of the longest safety track records among GHRH analogs.

Head-to-Head Comparison

Feature	CJC-1295	Sermorelin
Type	Modified GHRH analog	GHRH(1-29) analog
Half-Life	~8 days (DAC)	~10-20 minutes
FDA History	None	Previously approved
GH Pattern	Sustained elevation	Natural pulsatile
Price (2mg)	$35-55	$30-50
Research History	Moderate	Extensive

Key Differences

The critical difference is half-life: CJC-1295 with DAC lasts days while Sermorelin is cleared in minutes. This means CJC-1295 provides sustained GH elevation, while Sermorelin produces brief pulses that more closely resemble natural GH secretion patterns. Sermorelin has a stronger regulatory history, having been previously FDA-approved, giving it a more established safety profile in published literature.

Which Should You Choose?

Choose CJC-1295 for research requiring sustained GH elevation with less frequent dosing. Choose Sermorelin for studies where natural pulsatile GH release is preferred, or where a well-established safety profile is important. Sermorelin is often preferred for initial research due to its extensive published literature.

Frequently Asked Questions

Is Sermorelin safer than CJC-1295?

Sermorelin has a longer track record with previous FDA approval status, giving it more established safety data. CJC-1295 is newer with less long-term research data but has shown a favorable profile in available studies.

Can they be used together?

While both are GHRH analogs, some research protocols use CJC-1295 for baseline GH elevation with Sermorelin for additional pulsatile stimulation, though this is less common than CJC-1295/Ipamorelin combinations.